Annual CFO
-$141.22 M
-$151.88 M-1424.13%
31 December 2023
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares annual cash flow from operations is currently -$141.22 million, with the most recent change of -$151.88 million (-1424.13%) on 31 December 2023. During the last 3 years, it has fallen by -$133.88 million (-1823.22%). NAMS annual CFO is now -1424.13% below its all-time high of $10.66 million, reached on 31 December 2022.NAMS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$12.50 M
+$41.48 M+76.84%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares quarterly cash flow from operations is currently -$12.50 million, with the most recent change of +$41.48 million (+76.84%) on 30 September 2024. Over the past year, it has increased by +$34.47 million (+73.39%). NAMS quarterly CFO is now at all-time high.NAMS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$154.16 M
+$34.47 M+18.28%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares TTM cash flow from operations is currently -$154.16 million, with the most recent change of +$34.47 million (+18.28%) on 30 September 2024. Over the past year, it has dropped by -$46.01 million (-42.55%). NAMS TTM CFO is now -383.81% below its all-time high of -$31.86 million, reached on 31 March 2023.NAMS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAMS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1424.1% | +73.4% | -42.5% |
| 3 y3 years | -1823.2% | - | - |
| 5 y5 years | - | - | - |
NAMS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1424.1% | at low | at high | +77.1% | -383.8% | +18.3% |
| 5 y | 5 years | -1424.1% | at low | at high | +77.1% | -383.8% | +18.3% |
| alltime | all time | -1424.1% | at low | at high | +77.1% | -383.8% | +18.3% |
NewAmsterdam Pharma Company NV Ordinary Shares Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.50 M(-76.8%) | -$154.16 M(-18.3%) |
| June 2024 | - | -$53.98 M(-1.1%) | -$188.63 M(+15.0%) |
| Mar 2024 | - | -$54.60 M(+65.1%) | -$163.96 M(+16.1%) |
| Dec 2023 | -$141.22 M | -$33.07 M(-29.6%) | -$141.22 M(+30.6%) |
| Sept 2023 | - | -$46.98 M(+60.3%) | -$108.14 M(+76.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$29.30 M(-8.0%) | -$61.17 M(+92.0%) |
| Mar 2023 | - | -$31.86 M | -$31.86 M |
| Dec 2022 | $10.66 M(-136.1%) | - | - |
| Dec 2021 | -$29.51 M(+301.9%) | - | - |
| Dec 2020 | -$7.34 M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual cash flow from operations?
- What is the all time high annual CFO for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual CFO year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly cash flow from operations?
- What is the all time high quarterly CFO for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly CFO year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares TTM cash flow from operations?
- What is the all time high TTM CFO for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares TTM CFO year-on-year change?
What is NewAmsterdam Pharma Company NV Ordinary Shares annual cash flow from operations?
The current annual CFO of NAMS is -$141.22 M
What is the all time high annual CFO for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high annual cash flow from operations is $10.66 M
What is NewAmsterdam Pharma Company NV Ordinary Shares annual CFO year-on-year change?
Over the past year, NAMS annual cash flow from operations has changed by -$151.88 M (-1424.13%)
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly cash flow from operations?
The current quarterly CFO of NAMS is -$12.50 M
What is the all time high quarterly CFO for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high quarterly cash flow from operations is -$12.50 M
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly CFO year-on-year change?
Over the past year, NAMS quarterly cash flow from operations has changed by +$34.47 M (+73.39%)
What is NewAmsterdam Pharma Company NV Ordinary Shares TTM cash flow from operations?
The current TTM CFO of NAMS is -$154.16 M
What is the all time high TTM CFO for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high TTM cash flow from operations is -$31.86 M
What is NewAmsterdam Pharma Company NV Ordinary Shares TTM CFO year-on-year change?
Over the past year, NAMS TTM cash flow from operations has changed by -$46.01 M (-42.55%)